Presenting features and outcomes of ocular melanoma may differ on the basis of Fitzpatrick skin type (FST), according to the results of a review published in Clinics in Dermatology.
Health Professionals
Melanoma in Adolescents and Young Adults: Declining Incidence, Rising Mortality
Melanoma in adolescents and young adults (AYAs) has distinct epidemiologic characteristics, with a declining incidence over the past 2 decades but an increasing trend in all-cause and cancer-specific mortality among specific populations, according to study results published in Clinics in Dermatology.
Dr Long Highlights Long-Term Benefit of Dabrafenib/Trametinib in Melanoma
Georgina V. Long, MD, MSc, discussed the long-term follow-up data for the combination of adjuvant dabrafenib and trametinib in stage III BRAF-mutated melanoma.
Truong Factors Age and High-Grade Toxicity Risk Into IO Selection in Melanoma
EVENT REGION Illinois, Minnesota, Nebraska, Wisconsin